Press Releases

AIRNA Launches to Develop New Class of RNA Editing Therapeutics for Rare and Common Diseases

Advancing next-generation RESTORE+™ RNA editing platform based on pioneering research of founders Thorsten Stafforst and Jin Billy Li



Precision RNA base editing with engineered and endogenous effectors

Laura S Pfeiffer, Thorsten Stafforst. Nat Biotechnol. 2023 Sep 21.  doi: 10.1038/s41587-023-01927-0.


Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides

Merkle T, Merz S, Reautschnig P, Blaha A, Li Q, Vogel P, Wettengel J, Li JB, Stafforst T. Nat Biotechnol 2019, 37:133-138, doi: 10.1038/s41587-019-0013-6, PMID: 30692694.